Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains
Disease Models & Mechanisms · 2025
DOI: 10.1242/dmm.052451 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2025. Verfasst von Eglė Žymantaitė und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunology, National Cancer Institute, P. Baublio g. 3B, LT-08406 Vilnius, Lithuania. Hauptthemen laut MEDLINE: Ovarian Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vilnius University, Science Promotion Fund for Scientific Projects, 2024-2025, HORIZON-MSCA-2023-PF-01, Vilnius University.
Abstract (Originalsprache)
Continuous passaging of cancer cell lines can drive phenotypic and genotypic divergence, potentially compromising the reliability of such models. In this study, we show that two late-passage strains (S1 and S2) of ovarian cancer cell line SKOV3, although authenticated via short tandem repeat (STR) profiling as identical, exhibit substantial differences in morphology, transcriptomic signatures, ability to form 3D cultures and chemotherapeutic responses. Notably, S1 formed compact 3D spheroids and exhibited enhanced epithelial-mesenchymal transition (EMT) pathway activity, whereas S2 displayed a more proliferative, MYC-driven phenotype with larger spheroid structures requiring higher seeding densities. Transcriptomic analysis revealed pathways associated with hypoxia, EMT and angiogenesis in 3D culture, highlighting the complexity introduced by dimensionality in tumour modelling. Critically, S1 showed higher sensitivity to doxorubicin than S2 (IC50 of 0.12 µM versus 1.28 µM, P=0.0001), indicating how clonal evolution can confound drug-response assays. Ultimately, our findings suggest that although STR profiling remains essential for cell line authentication, functionally distinct subpopulations can arise and coexist within the same culture, and their isolation may reveal divergent phenotypes that compromise reproducibility in preclinical cancer research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunology, National Cancer Institute, P. Baublio g. 3B, LT-08406 Vilnius, Lithuania.
- Institute of Biosciences, Life Sciences Center, Vilnius University, Sauletekio 7, LT-10257 Vilnius, Lithuania.
- Institute of Biotechnology, Life Sciences Center, Vilnius University, Sauletekio 7, LT-10257 Vilnius, Lithuania.
- Department of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Sauletekio al. 11, LT-10223 Vilnius, Lithuania.
ORCID-Profile: Eglė Žymantaitė, Migle Gabrielaite, Vita Pašukonienė, Agata Mlynska
Förderung
- Vilnius University, Science Promotion Fund for Scientific Projects, 2024-2025
- HORIZON-MSCA-2023-PF-01
- Vilnius University
- European Commission
Zitieren
APA
Žymantaitė, E., Gabrielaite, M., Pašukonienė, V., & Mlynska, A. (2025). Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052451
Vancouver
Žymantaitė E, Gabrielaite M, Pašukonienė V, Mlynska A. Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains. Disease Models & Mechanisms. 2025. doi:10.1242/dmm.052451
BibTeX
@article{ymantait2025,
author = {Žymantaitė, Eglė and Gabrielaite, Migle and Pašukonienė, Vita and Mlynska, Agata},
title = {Extended passaging of the SKOV3 ovarian cancer cell line leads to two phenotypically different strains},
journal = {Disease Models & Mechanisms},
year = {2025},
doi = {10.1242/dmm.052451}
}
EUVIMED